Genomic Solutions Agena Bioscience specializes in targeted genomic data with the MassARRAY System, offering a scalable platform suitable for hospitals, CROs, and academic labs seeking high-mmultiplex mutation profiling, pharmacogenetics, and liquid biopsy applications to expand their test menus.

Expansion & Partnerships Recent and ongoing collaborations, including partnerships with Precision For Medicine and Alliance Global, indicate a strong channel strategy and access to new markets; leverage these relationships to co-sell MassARRAY panels and expand into emerging markets and translational research programs.

New Panel Opportunities The launch of broader cystic fibrosis genetic panels signals ongoing product development and adoption of multi-mutation assays; target genomic laboratories and clinical researchers needing comprehensive panels for rare mutations or pharmacogenomic-informed therapies.

Clinical & Research Footprint With a San Diego headquarters and global offices, Agena has a global footprint that can support multinational studies, cross-border clinical collaborations, and deployment of standardized MassARRAY workflows in partner sites and contract research organizations.

Financial & Growth Signals Revenue in the mid-range of tens of millions and a history of strategic M&A activity (notably acquisition by Mesa Labs) suggests investment capacity and potential for expanded product support, services, and training offerings to attract lab customers seeking end-to-end solutions.